Healthee Secures $50 Million in Series B Funding

Apr 23, 2025
Healthee has raised $50 million in a Series B funding round led by Key1 Capital, aiming to enhance its AI-powered health benefits platform.

Healthee has raised $50 million in a Series B funding round led by Key1 Capital, as announced in a press release. The funding round also saw participation from existing investors Fin Capital, Glilot Capital Partners, and Group11.

The funding follows a successful year for Healthee, which now serves over 15,000 customers, including notable clients like Instacart, SiriusXM, and Celonis. The company plans to use the new capital to expand its product suite, enhance its AI capabilities, and scale its go-to-market operations.

Healthee's platform aims to simplify the health benefits experience for both employers and employees by providing intuitive, AI-powered tools that improve care access and reduce costs. The company did not actively seek this funding round; instead, Key1 Capital approached them after observing the company's growth and potential.

We hope you enjoyed this article

Free newsletter

AI Funding Brief

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.